To capitalize on this exponential growth, one of Europe’s largest vertically integrated cannabis companies, Curaleaf International, part of Curaleaf Holdings (TSX: CURA), is expanding into the Czech Republic. This will be a new market for the company through a new supply agreement with Astrasana Pharma s.r.o. Through the partnership, Curaleaf International’s EU-GMP flower will be made available to patients via Pilulka Pharmacy, a leading healthcare provider in the region.
Curaleaf Internationla’s Head Juan Pablo Martinez had this to say, “Our partnership with Astrasana Pharma s.r.o. signifies another step forward in the growing European medical cannabis market. Together, we’re facilitating patient access and contributing to the evolution of the medicinal cannabis industry.”
Shares were trading up in afternoon trade.
Copyright © 2024 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com’s content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
]]>